Anne Broeg-Morvay1, Pasquale Mordasini1, Corrado Bernasconi1, Monika Bühlmann1, Frauke Pult1, Marcel Arnold1, Gerhard Schroth1, Simon Jung1, Heinrich P Mattle1, Jan Gralla1, Urs Fischer2. 1. From the Departments of Neurology (A.B.-M., C.B., M.B., M.A., S.J., H.P.M., U.F.) and Diagnostic and Interventional Neuroradiology (P.M., F.P., G.S., S.J., J.G.), Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland. 2. From the Departments of Neurology (A.B.-M., C.B., M.B., M.A., S.J., H.P.M., U.F.) and Diagnostic and Interventional Neuroradiology (P.M., F.P., G.S., S.J., J.G.), Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland. urs.fischer@insel.ch.
Abstract
BACKGROUND AND PURPOSE: Five randomized controlled trials have consistently shown that mechanical thrombectomy (MT) in addition to best medical treatment (±intravenous tissue-type plasminogen activator) improves outcome after acute ischemic stroke in patients with large artery anterior circulation stroke. Whether direct MT is equally effective as combined intravenous thrombolysis with MT (ie, bridging thrombolysis) remains unclear. METHODS: We retrospectively compared clinical and radiological outcomes in 167 bridging patients with 255 patients receiving direct MT because of large artery anterior circulation stroke. We matched all patients from the direct MT group who would have qualified for intravenous tissue-type plasminogen activator with controls from the bridging group, using multivariate and propensity score analyses. Functional independence was defined as modified Rankin Scale score of 0 to 2. RESULTS: From February 2009 to August 2014, 40 patients from the direct MT group would have qualified for bridging thrombolysis but were treated with MT only. Clinical and radiological characteristics did not differ from the bridging cohort, except for higher rates of hypercholesterolemia (P=0.019), coronary heart disease (P=0.039), and shorter intervals from symptom onset to endovascular intervention (P=0.01) in the direct MT group. Functional independence, mortality, and intracerebral hemorrhage rates did not differ (P>0.1). After multivariate matching analysis outcome in both groups did not differ, except for lower rates of asymptomatic intracerebral hemorrhage (P=0.023) and lower mortality (P=0.007) in the direct MT group. CONCLUSIONS: In patients with large anterior circulation stroke, direct mechanical intervention seems to be equally effective as bridging thrombolysis. A randomized trial comparing direct MT with bridging therapy is warranted.
BACKGROUND AND PURPOSE: Five randomized controlled trials have consistently shown that mechanical thrombectomy (MT) in addition to best medical treatment (±intravenous tissue-type plasminogen activator) improves outcome after acute ischemic stroke in patients with large artery anterior circulation stroke. Whether direct MT is equally effective as combined intravenous thrombolysis with MT (ie, bridging thrombolysis) remains unclear. METHODS: We retrospectively compared clinical and radiological outcomes in 167 bridging patients with 255 patients receiving direct MT because of large artery anterior circulation stroke. We matched all patients from the direct MT group who would have qualified for intravenous tissue-type plasminogen activator with controls from the bridging group, using multivariate and propensity score analyses. Functional independence was defined as modified Rankin Scale score of 0 to 2. RESULTS: From February 2009 to August 2014, 40 patients from the direct MT group would have qualified for bridging thrombolysis but were treated with MT only. Clinical and radiological characteristics did not differ from the bridging cohort, except for higher rates of hypercholesterolemia (P=0.019), coronary heart disease (P=0.039), and shorter intervals from symptom onset to endovascular intervention (P=0.01) in the direct MT group. Functional independence, mortality, and intracerebral hemorrhage rates did not differ (P>0.1). After multivariate matching analysis outcome in both groups did not differ, except for lower rates of asymptomatic intracerebral hemorrhage (P=0.023) and lower mortality (P=0.007) in the direct MT group. CONCLUSIONS: In patients with large anterior circulation stroke, direct mechanical intervention seems to be equally effective as bridging thrombolysis. A randomized trial comparing direct MT with bridging therapy is warranted.
Authors: Georgios Tsivgoulis; Aristeidis H Katsanos; Dimitris Mavridis; Anne W Alexandrov; Georgios Magoufis; Adam Arthur; Valeria Caso; Peter D Schellinger; Andrei V Alexandrov Journal: Ther Adv Neurol Disord Date: 2016-12-01 Impact factor: 6.570
Authors: Johannes Kaesmacher; Christian Maegerlein; Felix Zibold; Silke Wunderlich; Claus Zimmer; Benjamin Friedrich Journal: Eur Radiol Date: 2017-07-27 Impact factor: 5.315
Authors: Christopher Traenka; Simon Jung; Jan Gralla; Rebekka Kurmann; Christoph Stippich; Barbara Goeggel Simonetti; Henrik Gensicke; Hubertus Mueller; Karl Lovblad; Ashraf Eskandari; Francesco Puccinelli; Jochen Vehoff; Johannes Weber; Susanne Wegener; Levke Steiner; Georg Kägi; Andreas Luft; Roman Sztajzel; Urs Fischer; Leo H Bonati; Nils Peters; Patrik Michel; Philippe A Lyrer; Marcel Arnold; Stefan T Engelter Journal: Eur Stroke J Date: 2018-01-03
Authors: Ronen R Leker; Jose E Cohen; David Tanne; David Orion; Gregory Telman; Guy Raphaeli; Jacob Amsalem; Jonathan Y Streifler; Hen Hallevi; Pavel Gavriliuc; Natan M Bornstein; Anat Horev; Nour Eddine Yaghmour Journal: Interv Neurol Date: 2018-07-04
Authors: Romain Bourcier; Mayank Goyal; David S Liebeskind; Keith W Muir; Hubert Desal; Adnan H Siddiqui; Diederik W J Dippel; Charles B Majoie; Wim H van Zwam; Tudor G Jovin; Elad I Levy; Peter J Mitchell; Olvert A Berkhemer; Stephen M Davis; Imad Derraz; Geoffrey A Donnan; Andrew M Demchuk; Robert J van Oostenbrugge; Michael Kelly; Yvo B Roos; Reza Jahan; Aad van der Lugt; Marieke Sprengers; Stephane Velasco; Geert J Lycklama À Nijeholt; Wagih Ben Hassen; Paul Burns; Scott Brown; Emmanuel Chabert; Timo Krings; Hana Choe; Christian Weimar; Bruce C V Campbell; Gary A Ford; Marc Ribo; Phil White; Geoffrey C Cloud; Luis San Roman; Antoni Davalos; Olivier Naggara; Michael D Hill; Serge Bracard Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302